Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Smith

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Cancer Medicine|December 19, 2022
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT projectFabio Efficace, Karin Koinig, Francesco Cottone, et al.
British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.
Studies in Health Technology and Informatics|September 1, 2016
Key Data Elements in Myeloid LeukemiaJulian Varghese, Christian Holz, Phillip Neuhaus, et al.
BMJ Open|March 8, 2024
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trialEleanor M Hudson, Samantha Noutch, Joanne Webster, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2019
Incidence and Risk Factors of Early Onset Neonatal AKIJennifer R Charlton, Louis Boohaker, David Askenazi, et al.
BMC Cancer|July 2, 2021
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanomaOliver Coen, Pippa Corrie, Helen Marshall, et al.
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.
Haematologica|April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS RegistryBente Houtman, Adele Taylor, Corine Van Marrewijk, et al.
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Cancer Medicine|December 19, 2022
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT projectFabio Efficace, Karin Koinig, Francesco Cottone, et al.
British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.
Studies in Health Technology and Informatics|September 1, 2016
Key Data Elements in Myeloid LeukemiaJulian Varghese, Christian Holz, Phillip Neuhaus, et al.
BMJ Open|March 8, 2024
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trialEleanor M Hudson, Samantha Noutch, Joanne Webster, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2019
Incidence and Risk Factors of Early Onset Neonatal AKIJennifer R Charlton, Louis Boohaker, David Askenazi, et al.
BMC Cancer|July 2, 2021
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanomaOliver Coen, Pippa Corrie, Helen Marshall, et al.
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.
Haematologica|April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS RegistryBente Houtman, Adele Taylor, Corine Van Marrewijk, et al.
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
Pageof 13